vos-headline-type-email-header-062620

ISSUE HIGHLIGHTS

Thumbnail_Montage_Q3
ISPOR Conferences

Featured Video: Voices From the Conference: Credibility of RWE + Leveraging Cures

Virtual ISPOR Europe 2020
ISPOR Conferences

The Digital Endpoints Ecosystem and Protocols (DEEP) Initiative

Virtual ISPOR Europe 2020
ISPOR Conferences

Novel Methods for Modeling Treatment Sequencing

W9 Contact Tracing_Figure 1_344x300
ISPOR Conferences

Contact Tracing Policies for SARS-CoV-2: Lessons Learned to Inform Decision Makers

Fig1 W11_cropped map_344x300
ISPOR Conferences

The COVID-19 Trial Tracker: A Framework to Provide Real-Time Updates on Emerging Evidence

Virtual ISPOR Europe 2020
ISPOR Conferences

Preventing the Breakdown of the Healthcare System: How to Use the SIR Model to Allocate Medical Resources Better

W6_Surrogate Endpoints _Figure 1_344x300
ISPOR Conferences

The Use of Surrogate Endpoints in Regulatory and HTA Submissions

Thumbnail_Montage_Q2
ISPOR Conferences

Featured Video: Voices From the Conference: Value of Innovation + Scientific Evidence of COVID-19

Virtual ISPOR Europe 2020
ISPOR Conferences

Could International Reference Pricing “Go Viral” After COVID-19?

Virtual ISPOR Europe 2020
ISPOR Conferences

Hot off the Production Line! The New Generalized Risk Adjusted Cost-Effectiveness (GRACE) Model

Plenary 3_Figure 1_344x300
ISPOR Conferences

Much Ado About Little: Dealing With Limited RCT Evidence for Early HTA and Reimbursement Decisions

Virtual ISPOR Europe 2020
ISPOR Conferences

How Can We Balance Quantifying the Broad Societal Benefits of Vaccines with Paying for Them?

IP11_Multinational HTA_Figure 2 cropped_344x300
ISPOR Conferences

Multinational HTA: Does IT Really Benefit Public Health and Promote Access to Innovation?

Virtual ISPOR Europe 2020
ISPOR Conferences

Bridging the Gap: Pathways for Regulatory and HTA of Histology Independent Therapies

VOS Spotlight Thumbnails344x350_InterviewRichardCharter
ISPOR Conferences

Featured Video: Full-Length Video Interview With Richard Charter (Alira Health)

IP8_ Integrating Patient Preference in HTA_Figure 2_344x300
ISPOR Conferences

Integrating Patient Preference Into HTA

Virtual ISPOR Europe 2020
ISPOR Conferences

Patient and Public Involvement in Healthcare Decision Making: Are We Maximizing Opportunities?

Women in HEOR_Figure 2_344x300
ISPOR Conferences

Women in HEOR: Adapting to the New Normal

Virtual ISPOR Europe 2020
ISPOR Conferences

How Should Pharmaceutical Companies and Patients Share the Value Generated by New Medicines?

W2_ Guidelines for Economic Evaluation_Figure 1a_344x300
ISPOR Conferences

How Guidelines Keep Up With Emerging Technologies and Developing Methods

Virtual ISPOR Europe 2020
ISPOR Conferences

Is Europe Ready to Value and Reimburse the Next Medical Frontier?

VOS Spotlight Thumbnails344x300_Tuesday
ISPOR Conferences

Featured Video: The Link Between ACPIs and Value-Based Healthcare

Virtual ISPOR Europe 2020
ISPOR Conferences

Accounting for Caregiver Burden in HEOR

VOS Spotlight Thumbnails (2)
ISPOR Conferences

Featured Video: Welcome to ISPOR Europe 2020

Virtual ISPOR Europe 2020
ISPOR Conferences

Allocating Resources During a Pandemic: To HTA or Not to HTA?

IP3_Cures_Figure 2_344x300
ISPOR Conferences

The Meaning and Value of “Cure” Beyond Statistical Survival Models

Virtual ISPOR Europe 2020
ISPOR Conferences

International Collaboration in Response to the Global COVID-19 Pandemic

Plenary image_344x300
ISPOR Conferences

“New Deal” for Healthcare Systems: Mission Inspirational, Impossible, or Inevitable?

Virtual ISPOR Europe 2020
ISPOR Conferences

Will COVID-19 Accelerate the Adoption of Digital Health Technologies?

Fig 1_IP1_344x300
ISPOR Conferences

Is It Time to Find Greater Efficiencies in HTA for Rare Diseases and Cell and Gene Therapies?

COLUMNS

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×